GlassScriptPhysician profile
David M Podboy
NPI 1790075414
$3,707.56
in general payments reported to CMS, 2019-2025
22 companies · $61.11 in 2025
The $61.11 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $29.23 · 2021: $138 · 2022: $3,126 · 2023: $192 · 2024: $13.98 · 2025: $61.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,016.99 | 2022 | |
| Avanos Medical | $133.43 | 2019-2023 | On-Q* Pump and Accessories |
| Abbvie INC. | $93.40 | 2019-2023 | |
| Astellas Pharma US INC | $70.09 | 2023 | Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $39.49 | 2023 | Myfembree |
| Exeltis, USA INC. | $36.96 | 2020-2021 | |
| Organon LLC | $31.93 | 2021-2022 | |
| Therapeuticsmd, INC. | $27.57 | 2021 | |
| Myovant Sciences INC. | $26.71 | 2021-2022 | |
| Biogen, INC. | $24.83 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $24.05 | 2020-2021 | |
| Hologic Sales and Service, LLC | $19.67 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.55 | 2023 | Exparel |
| Bayer Healthcare Pharmaceuticals INC. | $18.40 | 2025 | |
| Conmed Corporation | $17.88 | 2025 | Visiclear, Airseal |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $17.86 | 2022 | |
| Shield Therapeutics INC | $17.27 | 2023 | Accrufer |
| Avion Pharmaceuticals | $17.08 | 2022 | |
| Convatec INC. | $16.59 | 2023 | |
| Currax Pharmaceuticals LLC | $13.98 | 2024 | Contrave |
| Amgen INC. | $13.69 | 2021 | |
| Novo Nordisk INC | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Podboy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.